Glyburide Structural Formula (Aadcb1a8 2605 40b3 A652 2787ec833278 01)
Glyburide
Product Images NDC 42254-281
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 42254-281). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure A: Single-dose Bioavailability Study (Aadcb1a8 2605 40b3 A652 2787ec833278 02)
The text describes a graph showing the concentration of two different formulations of Glyburide tablets over time. The concentration is plotted in ng/mL on the y-axis and time is plotted in hours on the x-axis. The two formulations being compared are Micronized Glyburide Tablets (3 mg) and Non-micronized Glyburide Tablets (5 mg).*
Glyburide 6mg (Aadcb1a8 2605 40b3 A652 2787ec833278 03)
This is a medication description for Glyburide 6mg tablets manufactured by Teva Canada Limited. Each tablet contains 6mg of Glyburide, and the product ID is QG028190. It is recommended to store this medication at a controlled room temperature of 15°-30°C (59*86°F).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
